Total Raised

$150.5M

Investors Count

19

Deal Terms

2

TytoCare Funding, TytoCare Valuation & TytoCare Revenue

8 Fundings

TytoCare's latest funding round was a Series D - II for $50M on March 4, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/4/2021

Series D - II

$50M

0

FY undefined

23

7/20/2020

Biz Plan Competition

0

FY undefined

10

4/7/2020

Series D

$99M

0

FY undefined

10

1/16/2019

Series C - II

$99M

0

FY undefined

10

1/29/2018

Series C

$99M

0

FY undefined

10

Date

3/4/2021

7/20/2020

4/7/2020

1/16/2019

1/29/2018

Round

Series D - II

Biz Plan Competition

Series D

Series C - II

Series C

Amount

$50M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

23

10

10

10

10

TytoCare Deal Terms

2 Deal Terms

TytoCare's deal structure is available for 2 funding rounds, including their Series B from July 15, 2015.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

TytoCare Investors

19 Investors

TytoCare has 19 investors. Shenzhen Capital Group invested in TytoCare's Series D - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/16/2019

3/4/2021

2
Series C - II, Series D - II (2021)

Venture Capital

China

4/7/2020

3/4/2021

2
Series D, Series D - II (2021)

Corporate Venture

California

4/7/2020

3/4/2021

2
Series D, Series D - II (2021)

Venture Capital

Israel

00/00/0000

00/00/0000

Insight Partners

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Qumra Capital

Subscribe to see more

Venture Capital

Israel

First funding

1/16/2019

4/7/2020

4/7/2020

00/00/0000

00/00/0000

Last Funding

3/4/2021

3/4/2021

3/4/2021

00/00/0000

00/00/0000

Investor

Insight Partners

Qumra Capital

Rounds

2
Series C - II, Series D - II (2021)
2
Series D, Series D - II (2021)
2
Series D, Series D - II (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Corporate Venture

Venture Capital

Venture Capital

Venture Capital

Location

China

California

Israel

New York

Israel

You May Also Like

Biofourmis Logo
Biofourmis

Biofourmis discovers, develops, and delivers clinically-validated, software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, technology for pharmaceutical companies to demonstrate value, and cost-effective solutions for payers. Biofourmis has built Biovitals, a personalized, AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of its digital therapeutics product pipeline across multiple therapeutic areas, including heart failure, oncology, acute coronary syndrome, COPD, and chronic pain. The company was founded in 2015 and is based in Boston, Massachusetts.

Eko Logo
Eko

Eko creates digital health solutions including AI-enabled stethoscopes, patient and provider software, and AI-powered analytics that enable doctors, nurses, researchers, and entire health systems to change care for the heart.

AliveCor Logo
AliveCor

AliveCor focuses on the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is a clinically validated mobile EKG solution on the market. It is recommended by cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG.

Glooko Logo
Glooko

Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.

MC10 Logo
MC10

MC10 is developing electronic systems through its Conformal Electronics Platform. The platform enhances and enables applications by allowing electronics to occupy spaces and geometries not possible in traditional, rigid form. Backed by a patent portfolio secured both through in-licensing and continued developments at MC10, the company is targeting applications in consumer electronics, medical devices, industrial products, and defense systems.

VitalConnect Logo
VitalConnect

VitalConnect currently markets the VitalConnect Platform that includes two wearable biosensors combined with mobile and cloud-based software and analytics. HealthPatch MD and VitalPatch biosensors are wireless, adhesive patches that continuously monitor and record single-lead ECG, heart rate, heart rate variability, respiratory rate, skin temperature, posture, step count, and fall detection with clinical accuracy. Through the VitalConnect Platform, care teams receive accurate data and notifications to make health decisions and enable timely interventions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.